In this scenario, corticotropin-releasing factor (CRF) might be a key player, as inhibiting its receptor (CRF1) could potentially alleviate symptoms associated with depression and overactive bladder (OAB) [4]. The gene discussed is CRH; the disease is overactive bladder.